The Gastrointestinal and Other Cancers Research conducts and supports prevention and early detection research on colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.
Barrett's Esophagus Translational Research Network (BETRNet)
Multi-disciplinary Research Centers collaborate to enhance understanding of Barrett's esophagus and prevent esophageal adenocarcinoma.
Cancer Prevention Clinical Trials Network (CP-CTNet)
Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
Major medical research centers conduct systematic early clinical development of promising preventive agents.
Think Tank on Aspirin and Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in Cancer Prevention
Date(s) and Time(s): 9/30/2021 9:00 a.m. - 1:30 p.m. ET; 10/1/2021: 9:00 a.m. - 1:00 p.m. ET, View the DRAFT Agenda for this meeting. WebEx information will be provided soon; please check back at a later date. No registration is required to attend.
Pancreatic Cysts Are Monitored in New Trial Aimed at Reducing Cancer Risk Through Targeted Screening
In a new NCI-sponsored study now recruiting participants, investigators will evaluate two different screening strategies for non-cancerous pancreatic cysts to determine which works best at detecting early malignancy.